Nls Pharmaceutics Ag Stock Technical Analysis

NLSP Stock  USD 0.13  0.01  7.14%   
As of the 24th of April, NLS Pharmaceutics secures the Mean Deviation of 4.18, market risk adjusted performance of 1.81, and Risk Adjusted Performance of (0.15). In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of NLS Pharmaceutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for NLS Pharmaceutics, which can be compared to its peers in the industry. Please verify NLS Pharmaceutics risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if NLS Pharmaceutics AG is priced more or less accurately, providing market reflects its recent price of 0.13 per share. As NLS Pharmaceutics appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.

NLS Pharmaceutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NLS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NLS
  
NLS Pharmaceutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

NLS Pharmaceutics Analyst Consensus

Target PriceAdvice# of Analysts
9.75Hold1Odds
NLS Pharmaceutics AG current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most NLS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NLS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NLS Pharmaceutics, talking to its executives and customers, or listening to NLS conference calls.
NLS Analyst Advice Details
NLS Pharmaceutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NLS Pharmaceutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NLS Pharmaceutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

NLS Pharmaceutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of NLS Pharmaceutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

NLS Pharmaceutics Trend Analysis

Use this graph to draw trend lines for NLS Pharmaceutics AG. You can use it to identify possible trend reversals for NLS Pharmaceutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NLS Pharmaceutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

NLS Pharmaceutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for NLS Pharmaceutics AG applied against its price change over selected period. The best fit line has a slop of   0.0075  , which may suggest that NLS Pharmaceutics AG market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2.11, which is the sum of squared deviations for the predicted NLS Pharmaceutics price change compared to its average price change.

About NLS Pharmaceutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NLS Pharmaceutics AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NLS Pharmaceutics AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NLS Pharmaceutics price pattern first instead of the macroeconomic environment surrounding NLS Pharmaceutics. By analyzing NLS Pharmaceutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NLS Pharmaceutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NLS Pharmaceutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

NLS Pharmaceutics April 24, 2024 Technical Indicators

Most technical analysis of NLS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NLS from various momentum indicators to cycle indicators. When you analyze NLS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

NLS Pharmaceutics April 24, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as NLS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether NLS Pharmaceutics is a strong investment it is important to analyze NLS Pharmaceutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NLS Pharmaceutics' future performance. For an informed investment choice regarding NLS Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NLS Pharmaceutics AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for NLS Stock analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is NLS Pharmaceutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NLS Pharmaceutics. If investors know NLS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NLS Pharmaceutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.50)
Return On Assets
(4.14)
Return On Equity
(8.63)
The market value of NLS Pharmaceutics is measured differently than its book value, which is the value of NLS that is recorded on the company's balance sheet. Investors also form their own opinion of NLS Pharmaceutics' value that differs from its market value or its book value, called intrinsic value, which is NLS Pharmaceutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NLS Pharmaceutics' market value can be influenced by many factors that don't directly affect NLS Pharmaceutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NLS Pharmaceutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NLS Pharmaceutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NLS Pharmaceutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.